Regulatory News
Thursday, March 24, 2016
REFILE-UPDATE 1-Ackman's hedge fund cooperating with U.S. on drug pricing probe -letter
BOSTON, March 24 (Reuters) - Billionaire investor William
Ackman, whose hedge fund is one of the biggest investors in drug
company Valeant, has been asked to supply information to U.S.
legislators...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment